{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:01:33Z","timestamp":1760043693804},"reference-count":37,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"unspecified","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"The George Institute for Global Health"},{"name":"Bethune Charity Foundation"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"published-print":{"date-parts":[[2020,1]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Diabetes management in primary care remains suboptimal in China, despite its inclusion in the essential public health service (EPHS). We aimed to evaluate the effectiveness of a mobile health (mHealth) based and three-tiered diabetes management system in diverse Chinese contexts.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and analysis<\/jats:title><jats:p>This is a cluster randomised controlled trial, named road to hierarchical diabetes management at primary care (ROADMAP). 19\u2009008 patients with type 2 diabetes (T2D) were recruited from primary care clinics in 864 communities across 144 counties\/districts of 24 provinces. Eligible participants were adult patients diagnosed with T2D and registered for diabetes management in communities. Patients within the same communities (clusters) were randomly allocated into the intervention or control arm for 1\u2009year in a 2:1 ratio. The control arm patients received usual care as EPHS packaged: at least four blood glucose (BG) and blood pressure (BP) tests, and lifestyle and medication instruction, yearly, from primary care providers. The intervention arm patients received at least two BG and one BP tests, monthly, and lifestyle and treatment instruction from a three-tiered contracted team. A mHealth platform,<jats:italic>Graded ROADMAP,<\/jats:italic>enabled test results uploading and sharing, and patient referral within the team. The intervention participants will be further divided into basic or intensive intervention group according to whether they were actively using the<jats:italic>Your Doctor<\/jats:italic>App. The primary outcome is the BG control rate with glycated haemoglobin (HbA1c)&lt;7.0%. Secondary outcomes include control rates and changes of ABC (HbA1c, BP and low-density lipoprotein cholesterol) and fasting BG, hypoglycaemia episodes and health-related quality of life (EuroQol (EQ-5D)).<\/jats:p><\/jats:sec><jats:sec><jats:title>Ethics and dissemination<\/jats:title><jats:p>The trial has been approved by the Institutional Review Board at Shanghai Sixth People's Hospital. Findings on the intervention effectiveness will be disseminated through peer-reviewed journals, conference presentations and other relevant mechanisms.<\/jats:p><\/jats:sec><jats:sec><jats:title>Trial registration number<\/jats:title><jats:p>ChiCTR-IOC-17011325.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjopen-2019-032734","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T23:28:02Z","timestamp":1578439682000},"page":"e032734","update-policy":"http:\/\/dx.doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":13,"title":["Study protocol for the road to hierarchical diabetes management at primary care (ROADMAP) study in China: a cluster randomised controlled trial"],"prefix":"10.1136","volume":"10","author":[{"given":"Weiping","family":"Jia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puhong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadila","family":"Duolikun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqian","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,1,6]]},"reference":[{"key":"2020050713292600000_10.1.e032734.1","unstructured":"International Diabetes Federation . IDF diabetes atlas. 8th edn. Brussels, Belgium: International Diabetes Federation, 2017. http:\/\/www.diabetesatlas.org"},{"key":"2020050713292600000_10.1.e032734.2","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S2213-8587(14)70102-0","article-title":"Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment","volume":"2","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2020050713292600000_10.1.e032734.3","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-015-0268-9"},{"key":"2020050713292600000_10.1.e032734.4","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1016\/S0140-6736(17)33109-4","article-title":"The primary health-care system in China","volume":"390","author":"Li","year":"2017","journal-title":"The Lancet"},{"key":"2020050713292600000_10.1.e032734.5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.15212\/FMCH.2018.0107","article-title":"Type 2 diabetes: challenges facing GPs","volume":"6","author":"Huo","year":"2018","journal-title":"Fam Med Community Health"},{"key":"2020050713292600000_10.1.e032734.6","doi-asserted-by":"crossref","unstructured":"Jin Y , Zhu W , Yuan B , et al . Impact of health workforce availability on health care seeking behavior of patients with diabetes mellitus in China. Int J Equity Health 2017;16.doi:10.1186\/s12939-017-0576-0","DOI":"10.1186\/s12939-017-0576-0"},{"key":"2020050713292600000_10.1.e032734.7","unstructured":"Ministry of finance, PRC (2019) report on the execution of the central and local budgets for 2018 and on the draft central and local budgets for, 2019. Available: http:\/\/www.xinhuanet.com\/english\/2019-03\/17\/c_137901687.htm [Accessed 25 Jun 2019]."},{"key":"2020050713292600000_10.1.e032734.8","unstructured":"Ministry of Health, PRC . Opinions on promoting the essential public health services gradually equalization, 2009. Available: http:\/\/www.nhc.gov.cn\/wjw\/gfxwj\/201304\/6cf4917e8af44fe28ac655f215f8e4ed.shtml [Accessed 25 Jun 2019]."},{"key":"2020050713292600000_10.1.e032734.9","unstructured":"People's Republic of China health system review. Manila : WHO Regional Office for the Western Pacific; 2015. (pg.20-21:139\u201342."},{"key":"2020050713292600000_10.1.e032734.10","unstructured":"National Health and Family Planning Commission of the People\u2019s Republic of China . China health and family planning statistical yearbook 2017. Beijing: Peking Union Medical College Publishing House, 2018."},{"key":"2020050713292600000_10.1.e032734.11","unstructured":"2016 health system reform progress monitoring report, 2017. Available: http:\/\/www.nhc.gov.cn\/tigs\/ygjb\/201707\/72dbee11426a48cfbe66325c20099c5f.shtml?from=singlemessage&isappinstalled=0#10006-weixin-1-52626-6b3bffd01fdde4900130bc5a2751b6d1. [Accessed 20 Sep 2019]."},{"key":"2020050713292600000_10.1.e032734.12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.168118"},{"key":"2020050713292600000_10.1.e032734.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2013.02.035"},{"key":"2020050713292600000_10.1.e032734.14","doi-asserted-by":"publisher","DOI":"10.4065\/mcp.2009.0649"},{"key":"2020050713292600000_10.1.e032734.15","unstructured":"International diabetes Federation. recommendations for managing type 2 diabetes in primary care, 2017. Available: www.idf.org\/managing-type2-diabetes [Accessed 25 Jun 2019]."},{"key":"2020050713292600000_10.1.e032734.16","doi-asserted-by":"crossref","unstructured":"Meng Q , Mills A , Wang L , et al . What can we learn from China\u2019s health system reform? BMJ 2019;l.","DOI":"10.1136\/bmj.l2349"},{"key":"2020050713292600000_10.1.e032734.17","doi-asserted-by":"crossref","unstructured":"Yuan B , Balabanova D , Gao J , et al . Strengthening public health services to achieve universal health coverage in China. BMJ 2019;33.doi:10.1136\/bmj.l2358","DOI":"10.1136\/bmj.l2358"},{"key":"2020050713292600000_10.1.e032734.18","doi-asserted-by":"crossref","unstructured":"Yue J , Mao X , Xu K , et al . Prevalence, awareness, treatment and control of diabetes mellitus in a Chinese population. PLoS One 2016;11:e0153791.doi:10.1371\/journal.pone.0153791","DOI":"10.1371\/journal.pone.0153791"},{"key":"2020050713292600000_10.1.e032734.19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/jdi.12175","article-title":"Factors associated with good glycemic control among patients with type 2 diabetes mellitus","volume":"5","author":"Ahmad","year":"2014","journal-title":"J Diabetes Investig"},{"key":"2020050713292600000_10.1.e032734.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2011.01.006"},{"key":"2020050713292600000_10.1.e032734.21","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.diabres.2016.04.001","article-title":"Diabetes education for Chinese adults with type 2 diabetes: a systematic review and meta-analysis of the effect on glycemic control","volume":"116","author":"Choi","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"2020050713292600000_10.1.e032734.22","doi-asserted-by":"crossref","unstructured":"Liu Y , Zhong L , Yuan S , et al . Why patients prefer high-level healthcare facilities: a qualitative study using focus groups in rural and urban China. BMJ Global Health 2018;3:e000854.doi:10.1136\/bmjgh-2018-000854","DOI":"10.1136\/bmjgh-2018-000854"},{"key":"2020050713292600000_10.1.e032734.23","unstructured":"State Council, PRC . Guiding opinions of the general office of the state Council on Propelling building of grading diagnosis and treatment system, 2015. Available: http:\/\/www.gov.cn\/zhengce\/content\/2015-09\/11\/content_10158.htm [Accessed 25 Jun 2019]."},{"key":"2020050713292600000_10.1.e032734.24","unstructured":"CPC Central Committee, State Council. The plan for \u201cHealthy China 2030\u201d, 2016. Available: http:\/\/www.gov.cn\/xinwen\/2016-10\/25\/content_5124174.htm [Accessed 25 Jun 2019]."},{"key":"2020050713292600000_10.1.e032734.25","doi-asserted-by":"crossref","unstructured":"Johnston L , Zemanek J , Reeve MJ , et al . The evidence for using mHealth technologies for diabetes management in low- and middle-income countries. J Hosp Manag Health Policy 2018;2.doi:10.21037\/jhmhp.2018.07.01","DOI":"10.21037\/jhmhp.2018.07.01"},{"key":"2020050713292600000_10.1.e032734.26","doi-asserted-by":"crossref","unstructured":"Reynolds R , Dennis S , Hasan I , et al . A systematic review of chronic disease management interventions in primary care. BMC Fam Pract 2018;19.doi:10.1186\/s12875-017-0692-3","DOI":"10.1186\/s12875-017-0692-3"},{"key":"2020050713292600000_10.1.e032734.27","doi-asserted-by":"crossref","unstructured":"Mitchell GK , Burridge L , Zhang J , et al . Systematic review of integrated models of health care delivered at the primary-secondary interface: how effective is it and what determines effectiveness? Aust J Prim Health 2015;21:391.doi:10.1071\/PY14172","DOI":"10.1071\/PY14172"},{"key":"2020050713292600000_10.1.e032734.28","doi-asserted-by":"crossref","unstructured":"Morrison F , Shubina M , Turchin A . Encounter frequency and serum glucose level, blood pressure, and cholesterol level control in patients with diabetes mellitus. Arch Intern Med 2011;171:1542.doi:10.1001\/archinternmed.2011.400","DOI":"10.1001\/archinternmed.2011.400"},{"key":"2020050713292600000_10.1.e032734.29","doi-asserted-by":"crossref","unstructured":"Coupe N , Peters S , Rhodes S , et al . The effect of commitment-making on weight loss and behaviour change in adults with obesity\/overweight; a systematic review. BMC Public Health 2019;19.doi:10.1186\/s12889-019-7185-3","DOI":"10.1186\/s12889-019-7185-3"},{"key":"2020050713292600000_10.1.e032734.30","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-008-0899-z"},{"key":"2020050713292600000_10.1.e032734.31","doi-asserted-by":"publisher","DOI":"10.1093\/intqhc\/mzr061"},{"key":"2020050713292600000_10.1.e032734.32","doi-asserted-by":"crossref","unstructured":"Song S , Yuan B , Zhang L , et al . Increased inequalities in health resource and access to health care in rural China. Int J Environ Res Public Health 2018;16:49.doi:10.3390\/ijerph16010049","DOI":"10.3390\/ijerph16010049"},{"key":"2020050713292600000_10.1.e032734.33","doi-asserted-by":"crossref","unstructured":"Zhang T , Xu Y , Ren J , et al . Inequality in the distribution of health resources and health services in China: hospitals versus primary care institutions. Int J Equity Health 2017;16.doi:10.1186\/s12939-017-0543-9","DOI":"10.1186\/s12939-017-0543-9"},{"key":"2020050713292600000_10.1.e032734.34","first-page":"885","article-title":"National Office for Primary Diabetes Care. National guidelines for the prevention and control of diabetes in primary care(2018)","volume":"57","year":"2018","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"2020050713292600000_10.1.e032734.35","unstructured":"National Bureau of statistics of China. China statistical Yearbook 2017, 2018. Available: http:\/\/www.stats.gov.cn\/tjsj\/ndsj\/2017\/indexeh.htm [Accessed 25 Jun 2019]."},{"key":"2020050713292600000_10.1.e032734.36","doi-asserted-by":"crossref","unstructured":"Zhou R , Wang W , Song Z-X , et al . Evaluation of a new hemoglobin A1c analyzer for point-of-care testing. J Clin Lab Anal 2018;32:e22172.doi:10.1002\/jcla.22172","DOI":"10.1002\/jcla.22172"},{"key":"2020050713292600000_10.1.e032734.37","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/dia.2015.0054","article-title":"Observational registry of basal insulin treatment (orbit) in patients with type 2 diabetes uncontrolled by oral hypoglycemic agents in China\u2014Study design and baseline characteristics","volume":"17","author":"Ji","year":"2015","journal-title":"Diabetes Technol Ther"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-032734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T02:06:36Z","timestamp":1601085996000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-032734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,10]]},"published-print":{"date-parts":[[2020,1]]}},"alternative-id":["10.1136\/bmjopen-2019-032734"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-032734","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1]]}}}